| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/11/2006 | US7074988 hybrid legume plants and seeds having herbicide, insect and disease resistance; genetic engineering; transgenic plants |
| 07/11/2006 | US7074986 hordein gene expression inhibition, by transfecting plants with nucleotide sequences that are linked in reverse orientation downstream of genetic enhancers within the plant, to generate antisense RNA complementary to endogenous hordien of the plant; genetic engineering |
| 07/11/2006 | US7074985 Development of a stress-responsive promoter from maize |
| 07/11/2006 | US7074983 Trangenic cell for use in human therapeutics and diagnostics |
| 07/11/2006 | US7074916 Concurrently separating double and single stranded polynucleotide sequences present in mixture via absorption of nucleic acids to mineral support; in vitro transcription |
| 07/11/2006 | US7074915 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof |
| 07/11/2006 | US7074914 Bactericides; polypeptides; genetic engineering |
| 07/11/2006 | US7074913 Receptor for B anthracis toxin |
| 07/11/2006 | US7074912 Identification and isolation of DNA and recombinant production of polypeptides |
| 07/11/2006 | US7074911 Comprises nucleotide sequences coding tumor protease which is are activated when inserted into genome in association with alternative promoters or transcriptional start sites; gene therapeutic tools for treatment of metabolic and cancer defects |
| 07/11/2006 | US7074910 PRO4340 nucleic acids |
| 07/11/2006 | US7074909 Prevent, therapy of disease; isolated nucleic acid which codes antibody; binding to human antigen |
| 07/11/2006 | US7074908 Protein for use in the treatment of lysosomal storage defects |
| 07/11/2006 | US7074905 An empty sc-MHC class II molecule comprising a peptide binding groove and a class II beta 2 chain comprising at least one amino acid substitution or deletion; immunosuppressants |
| 07/11/2006 | US7074901 Nucleotide sequences coding polypeptides for use in the tumor/cancer therapy |
| 07/11/2006 | US7074899 A polypeptides, polynucleotides, gene expression host cells, use in drug screening and diagnosis of potential agonists, antagonists |
| 07/11/2006 | US7074898 Polypeptide for use as an antiproliferative agent in the treatment of cell proliferative disorders |
| 07/11/2006 | US7074896 Gene expression of nucleic acid in prokaryotic cells; homogeneity, purity; immobilization; separation of antibodies by chromatography |
| 07/11/2006 | US7074894 Antigen composition against mycoplasma |
| 07/11/2006 | US7074891 Stimulant releasing of archidonic acid from target cells; polypeptides; induction gene expression |
| 07/11/2006 | US7074889 Identification of a new cytotoxic activity from the ink of Aplysia punctata |
| 07/11/2006 | US7074772 Expression vector for use in the transfer of genetic information |
| 07/11/2006 | US7074771 Gene encoding MNR2 and uses thereof |
| 07/11/2006 | US7074769 Antisense oligonucleotide or analog thereof comprising 10 or more contiguous bases or base analogs; for treating cancer |
| 07/11/2006 | US7074768 Modified protein kinase A-specific oligonucleotides and methods of their use |
| 07/11/2006 | US7074757 Gene expression in Escherichia; fusion protein; chimera; cloning genes; splitting using thrombin; genetic engineering; prevent proteolysis during purification |
| 07/11/2006 | US7074618 Adenovirus culture product which lacks reproduction; binding to promoters; package cell line; separation of vectors, gene expression |
| 07/11/2006 | US7074617 MHC class II antigen-presenting systems and methods for activatind CD4+T cells |
| 07/11/2006 | US7074616 Aids screening using polypeptides; genetic engineered cells |
| 07/11/2006 | US7074614 Clock gene BMAL2 |
| 07/11/2006 | US7074613 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 07/11/2006 | US7074611 Method for the stable inversion of DNA sequence by site-specific recombination and DNA vectors and transgenic cells thereof |
| 07/11/2006 | US7074607 Polynucleotide sequences which encode the zwa1 gene |
| 07/11/2006 | US7074606 Microorganism utilizing propionamide for use in preparation of therapeutic amides |
| 07/11/2006 | US7074604 Bioproduction of astaxanthin using mutant carotenoid ketolase and carotenoid hydroxylase genes |
| 07/11/2006 | US7074602 Escherichia coli (E. coli) strain capable of producing L-threonine in high yield; expression repression of threonine biosynthesis genes by a metJ gene product is prevented, thereby producing a high concentration of threonine |
| 07/11/2006 | US7074601 Nucleozymes |
| 07/11/2006 | US7074595 Complete removal of endosperm contaminated is changed to selenomethionine and a cell-free protein synthesis is carried out using a reaction solution form protein biosynthesis containing selenomethionine instead of methionine |
| 07/11/2006 | US7074594 A full-length cDNA encoding a human-derived G protein-coupled receptor protein is isolated by screening a human hippocampus library; lows intracellular cAMP concentration under stimulation with histamine; usable for screening ligands or in screening candidate compounds for drugs |
| 07/11/2006 | US7074593 PRO 703 nucleic acids |
| 07/11/2006 | US7074592 Nucleotide sequences coding membrane proteins for use in treatment of cancer, infections, cardiavascular, nervous system, skin and kidney disorders |
| 07/11/2006 | US7074591 Polynucleotides encoding human GABA receptors |
| 07/11/2006 | US7074590 Chimeric promoters |
| 07/11/2006 | US7074588 production of cyclic ketocarotenoid compounds by providing a host cell which produces monocyclic or bicyclic carotenoids, transforming the host cell with an isolated nucleic molecule encoding the carotenoid ketolase enzyme, growing the transformed cell under conditions to produce the ketocarotenoids |
| 07/11/2006 | US7074587 Astaxanthin synthase |
| 07/11/2006 | US7074584 Yeast arrays, methods of making such arrays, and methods of analyzing such arrays |
| 07/11/2006 | US7074574 Method of detecting growth differentiation factor-7 (GDF-7) using GDF-7 antibodies |
| 07/11/2006 | US7074571 Serine carboxypeptidase hx (SCPhx) and compositions thereof |
| 07/11/2006 | US7074569 Mobility-modified nucleobase polymers and methods of using same |
| 07/11/2006 | US7074566 Determining interference or disturbance in the co-modulation mechanism between androgen receptor proteins and the coactivator arginine methyltransferase (HSRNAAM) |
| 07/11/2006 | US7074565 Preparation of DNA-containing extract for PCR amplification |
| 07/11/2006 | US7074564 Rolling circle replication of padlock probes |
| 07/11/2006 | US7074563 Mass spectrometric methods for detecting mutations in a target nucleic acid |
| 07/11/2006 | US7074560 Purification of tissue plasminogen activator (tPA) |
| 07/11/2006 | US7074559 Comprises nucleotide sequences coding mycobacterium paratuberculosis polypeptides for immunization and prevention of mycobacterial animal infections |
| 07/11/2006 | US7074557 Isolating preferentially binding particles; obtain nucleotide sequences, incubate with translation appataratus, expose to preferential particles, recover encapsulated complex |
| 07/11/2006 | US7074556 Generating preferential nucleotide sequences; obtain mesenger ribonucleic acids, mix with polymerase, incubate, recover nucleotide sequences |
| 07/11/2006 | US7074519 Molehole embedded 3-D crossbar architecture used in electrochemical molecular memory device |
| 07/11/2006 | US7074414 Cold-adapted equine influenza viruses |
| 07/11/2006 | US7074413 Using reverse genetics to combine the antigenic determinants that render the rabies virus non-pathogenic with the determinants that are responsible for the elicitation of an effective anti-rabies immune response |
| 07/11/2006 | US7074411 α-β C4BP-type recombinant heteromultimeric proteins |
| 07/11/2006 | US7074410 Modified HCV peptide vaccines |
| 07/11/2006 | US7074408 Use of integrin antagonists to inhibit angiogenesis |
| 07/11/2006 | US7074406 Treating allergic diseases with humanized anti-CD40L antibody |
| 07/11/2006 | US7074400 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene |
| 07/11/2006 | US7074398 p21 genes/proteins/fragments; antiproliferative agents; antitumor agents; restenosis |
| 07/11/2006 | US7074367 Thermostated block with heat-regulating devices |
| 07/11/2006 | CA2440583C A proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 07/11/2006 | CA2352490C Magnetic particles for purifying nucleic acids |
| 07/11/2006 | CA2335387C Method for analyzing phyletic lineage of scallop |
| 07/11/2006 | CA2277983C Tyrosine phosphorylated cleavage furrow-associated proteins (pstpips) |
| 07/11/2006 | CA2207013C Application of bio-spectrum in animal embryonic engineering |
| 07/11/2006 | CA2198210C Non self-inactivating, expression targeted retroviral vectors |
| 07/11/2006 | CA2176463C Hu-b1.219, a novel human hematopoietin receptor |
| 07/11/2006 | CA2148499C Method for transforming monocotyledons using scutella of immature embryos |
| 07/11/2006 | CA2117536C Immunological detection of organophosphates |
| 07/11/2006 | CA2078549C Multiple sclerosis t-cell receptor |
| 07/06/2006 | WO2006072078A2 Bioproduction of astaxanthin using mutant carotenoid ketolase and cartonenoid hydroxylase genes |
| 07/06/2006 | WO2006072016A2 Methods for regulation of stem cells |
| 07/06/2006 | WO2006071878A1 Methods and compositions for treating epithelial cancers |
| 07/06/2006 | WO2006071776A2 Ligation-based rna amplification |
| 07/06/2006 | WO2006071746A2 Engineered dopamine neurons and uses thereof |
| 07/06/2006 | WO2006071691A2 Rnai inhibition of serum amyloid a for treatment of glaucoma |
| 07/06/2006 | WO2006071598A1 Neutral cellulase catalytic core and method of producing same |
| 07/06/2006 | WO2006071435A2 Methods for correcting mitotic spindle defects and optimizing preimplantation embryonic developmental rates associated with somatic cell nuclear transfer in animals |
| 07/06/2006 | WO2006071410A2 Apparatus and system having dry gene silencing compositions |
| 07/06/2006 | WO2006071280A1 Immunoglobulins comprising predominantly a ga1g1cnacman5glcnac2 glycoform |
| 07/06/2006 | WO2006071219A1 Improved grain quality through altered expression of seed proteins |
| 07/06/2006 | WO2006071203A2 L-arabinose isomerase exhibiting minimum dependence on metal ions for its activity and for thermostability, isolated and characterized nucleotide sequence thereof |
| 07/06/2006 | WO2006071099A1 Novel l-lysine-inducible promoter |
| 07/06/2006 | WO2006071028A1 Method for preparing transformants expressing benzaldehyde dehydrogenase and prepation of 2,6-naphthalene dicarboxylic acid using the transformants |
| 07/06/2006 | WO2006070901A1 Method of detecting repeated polymorphism in human heparin/heparan sulfate binding protein and utilization of the same |
| 07/06/2006 | WO2006070860A1 Novel screening method for inflammatory cytokine inhibitor |
| 07/06/2006 | WO2006070815A1 Fusarium toxin resistant transformed plant |
| 07/06/2006 | WO2006070804A1 Method of inhibiting telomerase activity and inhibitor |
| 07/06/2006 | WO2006070776A1 Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody |
| 07/06/2006 | WO2006070752A1 Control program and culture apparatus |
| 07/06/2006 | WO2006070729A1 Insulin-producing cell-specific promoter and the use thereof |
| 07/06/2006 | WO2006070718A1 Drugs for diseases accompanying changes in total bile acid pool or lipid metabolism disorders and method of screening these drugs |
| 07/06/2006 | WO2006070667A1 Method of detecting mutation in egfr gene and detection kit |